Last reviewed · How we verify
NCT04211883
Project ACTIVE a Clinical Intervention
NA trial testing ACTIVE intervention in Alcohol Abuse in 140 participants. Completed in 2 May 2018.
2 May 2018
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 140 |
| Start date | 20 January 2016 |
| Primary completion | 2 May 2018 |
| Estimated completion | 2 May 2018 |
Drugs / interventions tested
- ACTIVE intervention — full drug profile →
Conditions studied
- Alcohol Abuse — all drugs for Alcohol Abuse →
- Obesity — all drugs for Obesity →
Sponsor
NYU Langone Health — full company profile →
Who can join
Adults 18 to 65, any sex, with Alcohol Abuse or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a clinical Randomized Controlled Trial where the study personnel will run a personalized prevention clinic with patients in attempts to improve their preventive health outcomes and compare their health outcomes with a matched control sample of patients who do not receive the clinical intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Project ACTIVE: a Randomized Controlled Trial of Personalized and Patient-Centered Preventive Care in an Urban Safety-Net Setting.
Applegate M, Scott E, Taksler GB, Sanchez M, et al · · 2021 · cited 8× · PMID 33443695 · DOI 10.1007/s11606-020-06359-z
Verify or expand the search:
- PubMed search for NCT04211883
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Abuse
Currently open trials in the same condition.
- NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
- NCT07216872 — Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use · NA · recruiting
- NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder · NA · recruiting
- NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
- NCT06265506 — Virtual Incentive Treatment for Alcohol · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04211883 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 3 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04211883.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing